285 related articles for article (PubMed ID: 31972596)
1. NKX3-1 Is a Useful Immunohistochemical Marker of EWSR1-NFATC2 Sarcoma and Mesenchymal Chondrosarcoma.
Yoshida KI; Machado I; Motoi T; Parafioriti A; Lacambra M; Ichikawa H; Kawai A; Antonescu CR; Yoshida A
Am J Surg Pathol; 2020 Jun; 44(6):719-728. PubMed ID: 31972596
[TBL] [Abstract][Full Text] [Related]
2. NKX3.1 a useful marker for mesenchymal chondrosarcoma: An immunohistochemical study.
Syed M; Mushtaq S; Loya A; Hassan U
Ann Diagn Pathol; 2021 Feb; 50():151660. PubMed ID: 33302222
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation profiling distinguishes Ewing-like sarcoma with EWSR1-NFATc2 fusion from Ewing sarcoma.
Koelsche C; Kriegsmann M; Kommoss FKF; Stichel D; Kriegsmann K; Vokuhl C; Grünewald TGP; Romero-Pérez L; Kirchner T; de Alava E; Diaz-Martin J; Hartmann W; Baumhoer D; Antonescu CR; Szuhai K; Flucke U; Dirksen U; Pfister SM; Jones DTW; Mechtersheimer G; von Deimling A
J Cancer Res Clin Oncol; 2019 May; 145(5):1273-1281. PubMed ID: 30895378
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of NKX2-2 expression in round cell sarcomas and other tumors with EWSR1 rearrangement: imperfect specificity for Ewing sarcoma.
Hung YP; Fletcher CD; Hornick JL
Mod Pathol; 2016 Apr; 29(4):370-80. PubMed ID: 26847175
[TBL] [Abstract][Full Text] [Related]
5. NFATc2-rearranged sarcomas: clinicopathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic marker.
Perret R; Escuriol J; Velasco V; Mayeur L; Soubeyran I; Delfour C; Aubert S; Polivka M; Karanian M; Meurgey A; Le Guellec S; Weingertner N; Hoeller S; Coindre JM; Larousserie F; Pierron G; Tirode F; Le Loarer F
Mod Pathol; 2020 Oct; 33(10):1930-1944. PubMed ID: 32327700
[TBL] [Abstract][Full Text] [Related]
6. EWSR1/FUS-NFATc2 rearranged round cell sarcoma: clinicopathological series of 4 cases and literature review.
Diaz-Perez JA; Nielsen GP; Antonescu C; Taylor MS; Lozano-Calderon SA; Rosenberg AE
Hum Pathol; 2019 Aug; 90():45-53. PubMed ID: 31078563
[TBL] [Abstract][Full Text] [Related]
7. Report and literature review of four cases of EWSR1::NFATC2 round cell sarcoma.
Liu L; Li L; Ding Y; Kong F; Mo W; Ye H; Shen D
Diagn Pathol; 2024 Jan; 19(1):19. PubMed ID: 38254207
[TBL] [Abstract][Full Text] [Related]
8. Confirmation of NKX3-1 Expression in EWSR1-NFATC2 Sarcoma and Mesenchymal Chondrosarcoma Using Monoclonal Antibody Immunohistochemistry, RT-PCR, and RNA In Situ Hybridization.
Yoshida A; Hashimoto T; Ryo E; Yoshida KI; Motoi T; Yatabe Y; Mori T
Am J Surg Pathol; 2021 Apr; 45(4):578-582. PubMed ID: 33443863
[No Abstract] [Full Text] [Related]
9. The diagnostic utility of cytology specimen in a case of EWSR1::NFATC2 sarcoma.
Takeda N; Makise N; Kageyama H; Takahashi T; Katoh H; Odaka A; Oikawa M; Sugiyama T; Kawana H; Araki A; Kinoshita H; Hagiwara Y; Kamoda H; Yonemoto T; Itami M
Virchows Arch; 2024 Mar; 484(3):533-538. PubMed ID: 38483612
[TBL] [Abstract][Full Text] [Related]
10. Implementation of Copy Number Variations-Based Diagnostics in Morphologically Challenging
Brcic I; Scheipl S; Bergovec M; Leithner A; Szkandera J; Sotlar K; Suda AJ; Smolle MA; Kraus T; Rosenberg AE; Liegl-Atzwanger B; Igrec J
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555836
[TBL] [Abstract][Full Text] [Related]
11. Expanding the Spectrum of EWSR1-NFATC2-rearranged Benign Tumors: A Common Genomic Abnormality in Vascular Malformation/Hemangioma and Simple Bone Cyst.
Ong SLM; Lam SW; van den Akker BEWM; Kroon HM; Briaire-de Bruijn IH; Cleven AHG; Savci-Heijink DC; Cleton-Jansen AM; Baumhoer D; Szuhai K; Bovée JVMG
Am J Surg Pathol; 2021 Dec; 45(12):1669-1681. PubMed ID: 34081036
[TBL] [Abstract][Full Text] [Related]
12. Sarcomas with EWSR1::Non-ETS Fusion (EWSR1::NFATC2 and EWSR1::PATZ1).
Machado I; Llombart-Bosch A; Charville GW; Navarro S; Domínguez Franjo MP; Bridge JA; Linos K
Surg Pathol Clin; 2024 Mar; 17(1):31-55. PubMed ID: 38278606
[TBL] [Abstract][Full Text] [Related]
13. The clinical heterogeneity of round cell sarcomas with EWSR1/FUS gene fusions: Impact of gene fusion type on clinical features and outcome.
Tsuda Y; Zhang L; Meyers P; Tap WD; Healey JH; Antonescu CR
Genes Chromosomes Cancer; 2020 Sep; 59(9):525-534. PubMed ID: 32362012
[TBL] [Abstract][Full Text] [Related]
14. EWSR1-NFATC2 Translocation-associated Sarcoma Clinicopathologic Findings in a Rare Aggressive Primary Bone or Soft Tissue Tumor.
Wang GY; Thomas DG; Davis JL; Ng T; Patel RM; Harms PW; Betz BL; Schuetze SM; McHugh JB; Horvai AE; Cho SJ; Lucas DR
Am J Surg Pathol; 2019 Aug; 43(8):1112-1122. PubMed ID: 30994538
[TBL] [Abstract][Full Text] [Related]
15. NKX3.1 immunohistochemistry is highly specific for the diagnosis of mesenchymal chondrosarcomas: experience in the Australian population.
Ramanayake N; Vargas AC; Talbot J; Bonar F; Wong DD; Wong D; Mahar A; Karim R; Luk PP; Selinger C; Sioson L; Gill AJ; Maclean F
Pathology; 2021 Oct; 53(6):705-712. PubMed ID: 33640159
[TBL] [Abstract][Full Text] [Related]
16. A novel FUS::NFATC4 fusion detected in a sarcoma with morphological features overlapping with NFATC2 sarcomas.
Klubíčková N; Gross JM; Comová K; Kuruc J; Michal M
Histopathology; 2024 Jan; 84(2):413-415. PubMed ID: 37813649
[No Abstract] [Full Text] [Related]
17. NKX2.2 is a useful immunohistochemical marker for Ewing sarcoma.
Yoshida A; Sekine S; Tsuta K; Fukayama M; Furuta K; Tsuda H
Am J Surg Pathol; 2012 Jul; 36(7):993-9. PubMed ID: 22446943
[TBL] [Abstract][Full Text] [Related]
18. Identification of EWSR1-NFATC2 fusion in simple bone cysts.
Hung YP; Fisch AS; Diaz-Perez JA; Iafrate AJ; Lennerz JK; Nardi V; Bredella MA; Raskin KA; Lozano-Calderon SA; Rosenberg AE; Nielsen GP
Histopathology; 2021 May; 78(6):849-856. PubMed ID: 33316098
[TBL] [Abstract][Full Text] [Related]
19. Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, "undifferentiated small round cell tumors". A clinicopathologic, immunophenotypic and molecular analysis.
Machado I; Yoshida A; Morales MGN; Abrahão-Machado LF; Navarro S; Cruz J; Lavernia J; Parafioriti A; Picci P; Llombart-Bosch A
Ann Diagn Pathol; 2018 Jun; 34():1-12. PubMed ID: 29661713
[TBL] [Abstract][Full Text] [Related]
20. Ewing sarcoma and Ewing-like tumors.
Sbaraglia M; Righi A; Gambarotti M; Dei Tos AP
Virchows Arch; 2020 Jan; 476(1):109-119. PubMed ID: 31802230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
